TMZ, a chemotherapeutic regime for GBM, is an alkylating agent which breaks the DNA double-strand, thus causing cell cycle arrest and ultimately cell death [75].Patients with GBM whose tumors have a methylated promoter for the gene encoding MGMT have previously been found to be more likely to benefit from the addition of TMZ [5]. The gene discussed is MGMT; the disease is glioblastoma.